Maravai LifeSciences (MRVI) Social Stream



Maravai LifeSciences (MRVI): $13.67

-0.07 (-0.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRVI to Watchlist
Sign Up

Industry: Biotech


Ranked

of 382

in industry

MARAVAI LIFESCIENCES HOLDINGS INC (MRVI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MARAVAI LIFESCIENCES HOLDINGS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-19 8 $62 $32 $53.428 $13.74 288.85%
2021-11-11 8 $65 $32 $52.714 $13.74 283.65%
2022-01-23 6 $59 $49 $54.833 $13.74 299.08%
2022-02-08 6 $59 $42 $52.333 $13.74 280.88%
2022-02-24 6 $58 $42 $48.5 $13.74 252.98%
2022-05-06 6 $54 $40 $46.2 $13.74 236.24%
2022-05-09 6 $49 $40 $44.333 $13.74 222.66%
2022-05-20 6 $49 $40 $43.833 $13.74 219.02%
2022-07-19 7 $49 $35 $42.571 $13.74 209.83%
2022-08-05 7 $40 $30 $35.571 $13.74 158.89%
2022-08-13 7 $40 $30 $34.428 $13.74 150.57%
2022-10-23 7 $37 $30 $34 $13.74 147.45%
2022-11-04 7 $35 $17 $26.428 $13.74 92.34%
2022-12-07 8 $32 $17 $23.75 $13.74 72.85%
2023-01-03 9 $32 $17 $23.888 $13.74 73.86%
2023-02-08 10 $32 $16 $23.1 $13.74 68.12%
2023-02-24 10 $32 $15 $21.9 $13.74 59.39%
2023-03-01 11 $32 $15 $21.6 $13.74 57.21%

The Trend in the Analyst Price Target


Over the past 43 weeks, MRVI's average price target has gone down $24.6.

MRVI reports an average of 56.94% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-19 7 49 35 42.571 26.79 58.91%
2022-10-17 7 37 30 34.000 19.42 75.08%
2022-12-07 8 32 17 23.750 12.71 86.86%
2022-12-14 9 32 17 23.888 15.13 57.88%
2023-03-01 11 32 15 21.600 14.97 44.29%

MRVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 7 2 2 0 0 11

The Trend in the Broker Recommendations


Over the past 16 months, MRVI's average broker recommendation rating worsened by 0.41.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • MRVI has a greater upside potential (average analyst target price relative to current price) than 1787.15% of all US stocks.
  • MARAVAI LIFESCIENCES HOLDINGS INC's number of analysts covering the stock is greater than 351.82% of stocks in the large market cap category.
  • In terms of how MARAVAI LIFESCIENCES HOLDINGS INC fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 500.81% of that group.
  • MARAVAI LIFESCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -941.79% of stocks in the large market cap category.

In the Pharmaceutical Products industry, ABCL, RVMD, and BEAM are the three stocks most similar to MARAVAI LIFESCIENCES HOLDINGS INC regarding the price target and analyst recommendation information presented here.

Is MRVI a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6807 seconds.